Insider Buying: 4basebio PLC (LON:4BB) Insider Buys 1,151 Shares of Stock

4basebio PLC (LON:4BB) insider Amy Walker bought 1,151 shares of 4basebio stock in a transaction that occurred on Friday, February 28th. The shares were acquired at an average cost of GBX 1,120 ($14.23) per share, for a total transaction of £12,891.20 ($16,382.26).

4basebio Price Performance

4BB stock opened at GBX 1,091 ($13.86) on Tuesday. The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. 4basebio PLC has a 52 week low of GBX 821 ($10.43) and a 52 week high of GBX 1,820 ($23.13). The firm’s fifty day moving average is GBX 1,177.26 and its 200 day moving average is GBX 1,279.03. The firm has a market cap of £139.76 million, a P/E ratio of -1,398.72 and a beta of 1.09.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.